Patient 2 pertinent radiology and pathology.(A)Vaginal mass biopsy showing malignant mesothelial cells with sarcomatoid features (H&E 20X). (B) CT/PET scan showing uptake in vaginal mass. (C) CT/PET showing additional uptake in the cecum. (D) Surgical specimen from the cecum showing epithelioid mesothelial proliferation with heavy lymphoplasmacytic infiltrate (H&E 20X). (E) Post-treatment CT/PET showing resolution of the vaginal mass (as compared to B). (F) Post-treatment CT/PET showing persistence of the cecal mass (compared with C). Imaging of associated inguinal lymphadenopathy not shown. Personalized oncogenomics: clinical experience with malignant peritoneal mesothelioma using whole genome sequencing. Sheffield BS, Tinker AV, Shen Y, Hwang H, Li-Chang HH, Pleasance E, Ch'ng C, Lum A, Lorette J, McConnell YJ, Sun S, Jones SJ, Gown AM, Huntsman DG, Schaeffer DF, Churg A, Yip S, Laskin J, Marra MA - PloS one (2015). Not Altered. CC.